2016 SPRING - Understanding Disease through Mining Clinical Trial Data


The 2016 Spring PRISME Forum Technical Meeting was held Thursday, the 19th of May, 2016 by MSD at its MSD IT Global Innovation Center located at Riverview, Svornosti 3321/2, Prague 5 – 150 00.

The meeting was preceded by a networking reception the evening of Wednesday, the 18th of May.

PRISME Forum Technical Meeting Chair:
Thomas Lønborg-Jensen, Novo Nordisk

PRISME Forum Chair:
Olivier Gien, Sanofi



Thursday, May 21, 2015


Meeting hosted by MSD


Understanding Disease through Mining Clinical Trial Data

Standard measures of human physiology are no longer enough to guide the next generation of medicines. Advances in technology are enabling the generation of new data types with finer granularity and more dimensions in information content. A deeper understanding of disease is arising from molecular data generated on biospecimens from patients enrolled in clinical trials. Further understanding of disease and drug response may be achieved with continuous physiologic readouts using biosensor technologies. These data will drive target selection, patient stratification and understanding of therapeutic and adverse responses.

This technical meeting will cover the following topics:

– Ability to capture novel data types in a clinical trial, e.g. biosensor data, smart phone data

– Clinical Sample Data: Types and Analytical Methods/Models

– Workflows and processes for enabling the integration of clinical and molecular data

– Approaches that companies are following to enable broad re-use of data

– Analysis environment for the primary and secondary use of such data

– Bioethical (legal and privacy) and regulatory requirements for working with such data

– Example of data management by a company in another industry with similar data challenges

A PRISME Forum Technical Meeting Advisory Committee (TMAC) has been set up to provide guidance on agenda topics and appropriately qualified speakers.

The committee members are listed below:

Thomas Lønborg-Jensen Novo Nordisk Vice President, R&D IT
Nadir Ammour Sanofi eClinical Director
Jim McGurk Daiichi-Sankyo Senior Director R&D IT
Scott Oloff Boehringer-Ingelheim Executive Director of IT Research, Development, and Medicine Enablement
Dave Sedlock Takeda Head, Global Research IT
Nico Stanculescu PRISME Forum
Susie Stephens Pfizer Senior Director R&D BT
John Wise PRISME Forum Programme Coordinator

The PRISME Forum Technical Meeting Advisory Committee will be looking for qualified speakers to address relevant topics including:

  • Use cases:
    • demonstrating how new clinical trials paradigms can bring demonstrable value
    • from other industry sectors to gain new insights into data sharing and pre-competitive collaborations
  • Strategies for the deployment of mobile devices and/or wearables addressing data standards and regulatory compliance
  • Next Generation Clinical Trials Data Management – including data sharing, data provenance and metadata management
  • Secondary use of Clinical Trials data
  • Patient-centric approaches to the new clinical trials paradigms including privacy and ethics
  • The global clinical trials environment and the need to conform with different laws and regulations

PRISME Forum members will be able to identify and define new clinical trials opportunities (including technologies, services and business models) that can impact R&D in their parent companies and find opportunities to partner to deliver pre-competitive capabilities that increase the effectiveness of their bio-pharma R&D.


For more information or for any suggestions, please get in touch with John Wise, Programme Coordinator for the PRISME Forum: jcmwise@prismeforum.org or +44 7768 173518.

All sessions were held at the MSD’s Innovation Center located at Svornosti 3321/2, 150 00 Prague 5, Czech Republic.




Wednesday, May 18, 2016

18:45Gather in hotel lobby for departure to PRISME Forum Group Reception (Business Meeting delegates and Technical Meeting delegates)

Thursday, May 19, 2016

8:00Gather in the hotel lobby for shuttle departure to the meeting venue
8:30Check-in; poster installation
8:45Welcome NotesOlivier Gien, Chair, PRISME Forum; Global Head, Clinical IT, Sanofi
8:50IntroductionThomas Lønborg-Jensen, Technical Meeting Chair, PRISME Forum; VP R&D Project Execution, Novo Nordisk


Chair: Thomas Lønborg-Jensen, Technical Meeting Chair, PRISME Forum; VP R&D Project Execution, Novo Nordisk
9:00Advanced Analytics with Trial Data: a Cross-industry view of Best Practices for Leveraging Internal AssetsJonathan Usuka, Knowledge Expert, Pharmaceuticals & Medical Products, McKinsey
9:30IMI Code of Practice for the Secondary Use of Health DataAnne Bahr, R&D Privacy Officer, Sanofi
10:00A Trustworthy Ecosystem for Reusing Health Data for ResearchPascal Coorevits, Professor, Ghent University; VP for Research, EuroRec
10:30Coffee Break


Chair: Jim McGurk, Sr. Director, Data Architecture, R&D Informatics, Daiichi Sankyo
Governance Models for Secondary Use of Human DataKatherine Tucker, Senior Manager - Patient-level Data Sharing, Roche
PROACT: Engaging Patients Through Innovative GovernanceDónal Landers, Senior Director Physician, AstraZeneca
The Value of IT In Biomarker Execution: A Clinical User StoryRebecca Blanchard, Head of Clinical Pharmacogenomics and Operations, MSD
Scott Thomas, Director of IT, Translational Medicine, MSD
Technology View: Analytics Informing DecisionsMatej Adam, IBM Watson Health


Peter Gamble, Director, Research to Release, MSD IT Global Innovation Center
12:00Introductions - Poster Rotations (Three 15 minute rotations)
P1Evolving Aspects of Anonymisation in Data Re-UseDave Handelsman, Senior Director, Strategy and Product Development, d-Wise
Chris Olinger, Chief Technology Officer, d-Wise
P2Patient Engagement: The Intersection of Motivations, Activities and PhysiologyPeter Gamble, Director, Research to Release, MSD IT Global Innovation Center
P3Gaining Business Insight for Clinical Trials - Text Analytics for a Data-Driven ApproachJane Reed, Head of Life Science Strategy, Linguamatics
P4Mobile Solutions for (Diabetic) Clinical TrialsScott Dixon, Global Vice President, eCOA Sales, ERT
Helle Ingemann Nielsen, Project Manager - EDC Process Specialist, Novo Nordisk
P5De-Identification of Clinical Trial Data at Novo Nordisk A/S to Enable Secondary Use of Anonymized Data for ResearchAdel Salem, Senior Programmer, Novo Nordisk
P6Biobanking for Secondary Use of Clinical Samples and DataMartin Urban, Lead IT Business Consultant, Boehringer Ingelheim


Peter Gamble, Director, Research to Release, MSD IT Global Innovation Center
14:00Poster Session (Remaining three 15 minute rotations)


Chair: Nadir Ammour, Domain Head, Patients & Partner Mgt, Sanofi
14:45Anonymization and Sharing of Individual Patient Data from Clinical StudiesJason Coarse, Biostatistician, UCB


Chair: Thomas Lønborg-Jensen, VP R&D Project Execution, Novo Nordisk
15:15Legal, Regulatory & Ethical Issues in the Secondary Use of Genomics DataWendy Chung, Director, Clinical Genetics Program, Columbia University
16:00Coffee Break and Preparations for SESSION VI: Bringing It All Together – Table Captains will meet to frame the structure of the session. A slide will provide clear instructions for the round-table discussion groups.


Chair: David Sedlock, Head, Global Research IT, Takeda Pharmaceuticals
16:30Table Discussions – Supervised by Table Captains
17:15Plenary: Table Captains' Feedback
17:45Plenary: Discussion of readout; Determine next steps
18:15AwardsChair: Thomas Lønborg-Jensen, Technical Meeting Chair, PRISME Forum; VP R&D Project Execution, Novo Nordisk
18:30Networking Reception (return to hotel will follow at 19:30)
The hotel for this meeting is The Mamaison Hotel Riverside Prague located at:

Janáčkovo nábřeží 15
150 00, Prague 5
Czech Republic

To reserve a room, please use the following link to the discounted room block: http://bit.ly/1UCnR6M

If rooms may not available through this link, please contact the secretariat to ensure a room reservation at a discounted block price

Hotel website: Click here

Prague Ruzyne Airport (Václav Havel Airport Prague) is the largest international airport in the Czech Republic with more than 50 airlines flying in.

The national carrier is Czech Airlines, a member of the Sky Team group (along with Delta, Air France, and Alitalia).

The airport is located about 18 kilometers (11 miles) northwest from the center of Prague and the MSD facility.



Contact: +420 844 700 800

Payment possible by cash or credit card (AMEX is accepted)


logoTaxi service at guaranteed tariff prices based on the number of kilometers traveled.
Contacts: +420 220 113 892; +420 220 117 078; 420 722 555 525 fix@airportcars.cz      http://www.airportcars.cz


logoTaxi service at guaranteed tariff prices based on the number of kilometers traveled.

Contacts: +420 222 333 222; +420 221 102 211 http://www.aaaradiotaxi.cz

Contact counters of taxi operators are located at the arriving hall of Terminal 1 and 2. Departure points are displayed in front of arriving halls.

Prague’s main station, Praha Hlavni Nádraží (Metro Line C), is located almost in the city center. The MSD facility is about an 18 minute drive or taxi from the train station.

Praha Hlavni Nadrazi (Main Train Station)

Wilsonova 8, New Town, Prague 2 Czech Republic

Tel: +420 840 112 113

The nearest Metro station to the MSD facility is Andel (on Line B). It is about a 10 minute walk from the station (a map or smartphone to guide you is recommended).

Shuttles will be provided to transport attendees to and from the hotel and MSD facilities.
Some useful contacts to have at MSD:

Reception Desk:

+420 277 026 000

Zuzana Stejskalová – Office & Facility Manager:

+420 601 560 074

Lucie Herkusová – Office Coordinator:

+420 603 809 033

Tereza Vachlová – Travel Coordinator:



Important general contacts:

112 – Emergency Calls

155 – Medical First Aid

156 – Municipal Police

150 – Firefighters